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-Catenin plays essential roles in both cell–cell adhe-
sion and Wnt signal transduction, but what precisely
controls 
 
 
 
-catenin targeting to cadherin adhesive
complexes, or T-cell factor (TCF)-transcriptional complexes
is less well understood. We show that during Wnt signal-
ing, a form of 
 
 
 
-catenin is generated that binds TCF but
not the cadherin cytoplasmic domain. The Wnt-stimulated,
TCF-selective form is monomeric and is regulated by the
COOH terminus of 
 
 
 
-catenin, which selectively competes
cadherin binding through an intramolecular fold-back
mechanism. Phosphorylation of the cadherin reverses the
TCF binding selectivity, suggesting another potential layer
 
 
of regulation. In contrast, the main cadherin-binding form
of 
 
 
 
-catenin is a 
 
 
 
-catenin–
 
 
 
-catenin dimer, indicating
that there is a distinct molecular form of 
 
 
 
-catenin that can
interact with both the cadherin and 
 
 
 
-catenin. We propose
that participation of 
 
 
 
-catenin in adhesion or Wnt signal-
ing is dictated by the regulation of distinct molecular forms
of 
 
 
 
-catenin with different binding properties, rather than
simple competition between cadherins and TCFs for a single
constitutive form. This model explains how cells can control
whether 
 
 
 
-catenin is used independently in cell adhesion
and nuclear signaling, or competitively so that the two
processes are coordinated and interrelated.
 
Introduction
 
 
 
-Catenin is a cytoplasmic protein that plays essential roles in
two different cellular processes: calcium-dependent intercellular
adhesion and Wnt-mediated transcriptional activation (for re-
view see Gottardi et al., 2002). For cell–cell adhesion, 
 
 
 
-catenin
binds the cytoplasmic domain of cadherin adhesion receptors
along with the actin binding protein, 
 
 
 
-catenin, to bridge the
extracellular adhesive activity of cadherins with the underlying
actin cytoskeleton (Rimm et al., 1995). This cadherin-bound
pool of 
 
 
 
-catenin ultimately serves to link the cytoskeletal net-
works of adjacent cells, which is considered essential for normal
tissue architecture and morphogenesis (for review see Gumbiner,
2000). For nuclear signaling, 
 
 
 
-catenin binds the DNA binding
factor, T-cell factor (TCF)–Lef, and together this complex re-
cruits components of the general transcriptional machinery (e.g.,
TATA binding protein), as well as proteins involved in chromatin
modification and remodeling (e.g., the histone acetyltransferase,
p300/CBP and the ATPase, Brg-1) to coordinate the activation
of gene targets (Hecht et al., 1999, 2000; Barker et al., 2001;
Tutter et al., 2001). How 
 
 
 
-catenin binding to cell surface cad-
herins or DNA binding proteins is regulated, and the relationship
between these two functions, remain to be explored.
Why might the cell use a single protein for both cell–cell
adhesion and nuclear signaling? One possibility is that signal-
ing and adhesion are tightly coordinated through competition
for a common pool of 
 
 
 
-catenin. Indeed, some evidence sug-
gests that the signaling and adhesive pools of 
 
 
 
-catenin are in-
terrelated in this way. Overexpression of cadherins in 
 
Xenopus
 
and other systems can antagonize 
 
 
 
-catenin signaling activity
(Heasman et al., 1994; Fagotto et al., 1996; Sanson et al., 1996;
Orsulic et al., 1999), whereas reduction in the expression of
cadherins in 
 
Drosophila
 
 embryos can enhance 
 
 
 
-catenin sig-
naling (Cox et al., 1996). Although experimental manipulation
of cadherin levels can affect 
 
 
 
-catenin nuclear signaling, it is
not yet clear whether 
 
 
 
-catenin signaling in vivo is actually
regulated by changes in endogenous cadherin levels or func-
tion. Moreover, there is also evidence that these two processes
can occur largely independently of each other. For example,
cadherin loss-of-function is not often associated with enhanced
 
 
 
-catenin signaling (Caca et al., 1999; Vasioukhin et al., 2001),
and Wnt activation does not typically alter cell–cell adhesion,
although enhanced adhesive activity has been reported previ-
ously (Bradley et al., 1993; Hinck et al., 1994). Thus, how the
roles of 
 
 
 
-catenin in signaling and adhesion are controlled to
be either coordinated or independent remains to be elucidated.
In the cases where expression of cadherins antagonizes
 
 
 
-catenin nuclear signaling activity, inhibition occurs by direct
binding of 
 
 
 
-catenin to the cytoplasmic domain of cadherins, and
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sequestration from the nuclear compartment (Fagotto et al., 1996;
Orsulic et al., 1999; Shtutman et al., 1999; Gottardi et al., 2001).
Recent evidence argues that the signaling and adhesive forms of
 
 
 
-catenin may share molecularly similarities. For example, com-
parison of 
 
 
 
-catenin–cadherin and 
 
 
 
-catenin–TCF cocrystal
structures revealed that both 
 
 
 
-catenin ligands bind to exten-
sively overlapping regions along 
 
 
 
-catenin, and in some regions
engage identical residues (for review see Gottardi and Gumbiner,
2001). Given such similarity in binding mechanism between
 
 
 
-catenin–cadherin and 
 
 
 
-catenin–TCF complexes, we proposed
that the cadherin is such a favorable inhibitor of 
 
 
 
-catenin nu-
clear signaling, not only because it sequesters 
 
 
 
-catenin away
from the nucleus, but also because it can compete directly with
TCF for 
 
 
 
-catenin binding (Gottardi and Gumbiner, 2001).
Nonetheless, the functions of 
 
 
 
-catenin can be molecularly
distinct. For example, 
 
C. elegans
 
 uses three different 
 
 
 
-catenin
gene products for adhesion and signaling functions (Korswagen
et al., 2000). BAR-1 mediates Wnt signaling by forming a tran-
scription complex with the TCF homologue, POP-1, whereas
HMP-2 interacts exclusively with the cadherin gene product,
HMR-1. WRM-1 is involved in a divergent Wnt pathway where
it regulates POP-1 indirectly. Although this simple organism has
evolved three distinct genes to segregate adhesive from signaling
forms of 
 
 
 
-catenin, there is no evidence for multiple 
 
 
 
-catenin
gene products in vertebrates. A splice variant of 
 
 
 
-catenin lack-
ing the COOH-terminal transactivation domain has been identi-
fied in 
 
Drosophila
 
, however, which seems to function only in ad-
hesion (Loureiro and Peifer, 1998). Vertebrates, therefore, must
somehow be able to rely on a single 
 
 
 
-catenin gene product for
both adhesion and signaling functions.
The notion of a single molecular form of 
 
 
 
-catenin that
participates identically in cell adhesion and gene expression
seems to be over simplified. In SW480 tumor cells, a large frac-
tion of 
 
 
 
-catenin was found to be refractory to both cadherin-
and TCF-binding in vitro (Gottardi et al., 2001). This is due, at
least in part, to the interaction of 
 
 
 
-catenin with a 9-kD polypep-
tide, ICAT (Tago et al., 2000), which can prevent 
 
 
 
-catenin
binding to both TCF and cadherin proteins (Gottardi and Gum-
biner, 2004). The small fraction of 
 
 
 
-catenin that can bind to
TCF also can interact with the cadherin, which explains how
cadherin expression inhibits 
 
 
 
-catenin–TCF signaling and cell
growth in this cell line (Gottardi et al., 2001). Thus, cells contain
at least two distinct forms of 
 
 
 
-catenin, raising the possibility
that the binding properties of 
 
 
 
-catenin may be regulated. These
distinct forms were identified, however, in a tumor cell line har-
boring a mutation in the adenomatous polyposis coli (APC) tu-
mor suppressor gene product, which is known to deregulate the
normal degradation of 
 
 
 
-catenin in cells. Therefore, we sought to
examine the regulation of 
 
 
 
-catenin binding properties by its
physiological regulator, Wnt.
 
Results
 
Wnts regulate 
 
 
 
-catenin binding 
specificity
 
We sought to determine the binding properties of 
 
 
 
-catenin gen-
erated by Wnt signaling. Using an in vitro pull-down assay, we
find that cytosolic 
 
 
 
-catenin from cells stably expressing Wnt1
shows preferential binding to TCF-GST compared with a cad-
herin cytoplasmic domain-GST fusion protein (Fig. 1 A, lanes
1–4). The selective binding activity of 
 
 
 
-catenin does not require
stable, long-term expression of Wnt in cells, as similar binding
properties are observed in human embryonic kidney (HEK) 293T
cells incubated with Wnt3a-conditioned media for short periods
(Fig. 1 A, lanes 7 and 8). Importantly, this difference in binding
is not observed in the untreated or parental cell lines (Fig. 1, lanes
5, 6, 9, and 10), with recombinant 
 
 
 
-catenin purified from SF9
cells (Fig. 1 B), or in a cell line that contains elevated levels of
 
 
 
-catenin due to loss of the APC tumor suppressor (Fig. 1, lanes
11 and 12). These findings demonstrate that the differential binding
activity of 
 
 
 
-catenin is actually induced by Wnts, and is not sim-
ply due to binding differences between cad-GST and TCF-GST
recombinant proteins, nor to the accumulation of high levels of
cytosolic 
 
 
 
-catenin. Thus, Wnts may activate 
 
 
 
-catenin signaling
by generating a molecular form of 
 
 
 
-catenin that selectively
binds to the downstream transcription factor, TCF, as well as by
raising the overall cytosolic levels of 
 
 
 
-catenin.
 
 
 
-Catenin binding selectivity is 
determined by its COOH-terminal region
 
Several findings influenced our investigation of a mechanism
that could generate a form of 
 
 
 
-catenin that binds selectively to
TCF. The COOH terminus of 
 
 
 
-catenin can interact with the
armadillo repeat region of 
 
 
 
-catenin (Cox et al., 1999; Piedra et
al., 2001) and compete with 
 
 
 
-catenin binding to the cadherin
cytoplasmic domain in vitro (Castano et al., 2002). These ob-
Figure 1.  Wnt signaling generates a form of  -catenin that binds prefer-
entially to TCF-GST compared with cadherin-GST. (A) Detergent-free super-
natants were prepared from C57MG and Rat1 cells stably expressing
Wnt-1, and HEK293T cells incubated overnight   Wnt3a-conditioned
media (CM). Samples were affinity precipitated using equimolar amounts
of cad-GST or TCF-GST fusion proteins. GST gives no binding and is not
depicted. A fivefold excess of parental cell lysates was required to detect
a signal in lanes 5 and 6. Cytosolic  -catenin from C57MG parentals
binds cad-GST and TCF-GST proteins equivalently, like the Rat1 and
HEK293 controls (not depicted). The blot was probed with a pAb to
 -catenin. (B) Preferential binding of  -catenin to TCF-GST over cadherin-
GST is not observed with purified, recombinant  -catenin. Recombinant,
purified Xenopus  -catenin (Suh and Gumbiner, 2003) and  -catenin from
a C57MG/Wnt cytosolic fraction were affinity precipitated with cad-GST
and TCF-GST proteins, and blotted with an antibody to  -catenin. 
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servations raised the possibility that conformational changes in
the COOH terminus of 
 
 
 
-catenin, and in particular, a “closed”
conformation, might be incompatible with cadherin binding.
Because Wnt signaling alters 
 
 
 
-catenin binding to the cadherin
and TCF differently (Fig. 1), we sought to determine whether
the COOH terminus of 
 
 
 
-catenin might contribute to this bind-
ing selectivity. Indeed, although the COOH terminus of 
 
 
 
-cate-
nin can compete 
 
 
 
-catenin binding to the cadherin, as demon-
strated previously (Castano et al., 2002), its interaction with
TCF is not competed (Fig. 2 C). Thus, if a COOH-terminal
conformational change giving rise to a closed form of 
 
 
 
-cate-
nin were to occur during Wnt signaling, it could alter 
 
 
 
-catenin
ligand interactions selectively.
To determine whether the COOH-terminal region of en-
dogenous 
 
 
 
-catenin exhibits a different conformation as a result
of Wnt signaling, we examined whether epitopes are masked in
the TCF-selective, closed form. The ability of anti–NH
 
2
 
- and
COOH-terminal–directed mAbs to immunoprecipitate 
 
 
 
-catenin
after affinity depletion by cad-GST was examined (Fig. 2 D).
Although 
 
 
 
-catenin is immunoprecipitated similarly by the
NH
 
2
 
- and COOH-terminal antibodies from the total starting cy-
tosol (lanes 6 and 7), when the cadherin binding fraction is first
depleted by the cadherin-GST, the remaining 
 
 
 
-catenin is poorly
immunoprecipitated by the COOH-terminal antibody compared
with the NH
 
2
 
-terminal antibody (compare lanes 4 and 5). These
antibodies, therefore, recognize distinct forms of 
 
 
 
-catenin (see
Fig. 5 C), which may differ as a result of a conformational
change in the COOH terminus of 
 
 
 
-catenin that alters 
 
 
 
-catenin
binding to cadherins. Thus, the COOH-terminal region of 
 
 
 
-cate-
nin is more accessible in the cadherin-binding fraction of 
 
 
 
-cate-
nin, and much less accessible in the nonbinding fraction.
To further determine the regions of 
 
 
 
-catenin control this
binding selectivity, we also examined the binding properties of a
series of  -catenin deletion mutants expressed in cells. Full-
length NH2-terminal myc-, or COOH-terminal flag-tagged
 -catenin exhibits preferential binding to TCF-GST relative to
cad-GST when transfected into HEK293 cells incubated with
Wnt3a-conditioned media (Fig. 3). Importantly, the level of ex-
ogenous  -catenin expression needed to be kept low in order to
detect  -catenin binding selectivity (compare 0.2  g with 2  g
plasmid), suggesting that the cellular machinery responsible for
generating binding selectivity may be easily saturable. As a con-
trol, simply diluting the sample transfected with 2  g plasmid
by 10-fold, so that the  -catenin levels were similar to those ex-
tracts transfected with 0.2  g plasmid, did not result in differen-
tial binding (unpublished data), indicating that binding selectiv-
ity is due to an active cellular process. A construct bearing a
deletion of the COOH terminus (h -cat C695) shows equiva-
lent binding to both cadherin and TCF, consistent with a role for
the COOH terminus in regulating binding selectivity. Curiously,
however, deletion of both NH2- and COOH-terminal domains
generates a protein that binds TCF significantly better than the
cadherin, even at relatively high levels of expression (e.g., com-
pare 3  g plasmid for X -cat arm 12 with WTX- -cat 2  g). It
was recently proposed that the NH2-terminal region of  -catenin
may be required for efficient cadherin binding, as a GST- -cate-
nin fusion protein missing the first 119 aa showed little cadherin
binding activity in vitro (Castano et al., 2002). We also find that
 89 -catenin binds poorly to the cadherin compared with TCF,
even at our highest expression levels (Fig. 3). Thus, we suggest
that the NH2-terminal region of  -catenin is required for cad-
herin but not TCF binding, which gives rise to apparent binding
selectivity. When  -catenin is able to bind the cadherin (i.e.,
when the NH2 terminus is present), however, the COOH termi-
nus is required for generating  -catenin binding selectivity.
Cadherin preferentially binds  -catenin– -
catenin complexes
To better characterize the molecular forms of  -catenin that
bind to cad-GST and TCF-GST fusion proteins, we examined
Figure 2. The COOH terminus of  -catenin restricts binding to cadherin.
COOH terminus of  -catenin competes cadherin, but not TCF binding.
(A) Schematic shows where  -catenin, cadherin, and TCF interact with
 -catenin (Huber et al., 1997; Graham et al., 2000; Pokutta and Weis,
2000; Huber and Weis, 2001). (B) The COOH terminus of  -catenin
binds the arm repeat region of  -catenin in yeast-two hybrid (Cox et al.,
1999) and recombinant protein assays (Piedra et al., 2001). (C) COOH-
terminal region of  -catenin competes  -catenin binding to cad-GST, but
not to TCF-GST fusion protein. Recombinant  -catenin (1.5  g) purified
from baculovirus (Suh and Gumbiner, 2003) was incubated with cadherin-
GST (2  g) or TCF-GST (2.4  g) coupled agarose beads in the presence
of increasing amounts of  -catenin COOH-terminal peptide (amino acids
695–781). Affinity precipitates were analyzed by SDS-PAGE and Western
blotting with an antibody to  -catenin. (D) Cadherin-GST preferentially
depletes the fraction of  -catenin recognized by a COOH-terminal mAb
(M5.2). A cytosolic fraction from Rat1/Wnt cells was affinity precipitated
( 3) with cadherin-GST (lanes 1–3). The cad-GST nonbinding pool (lanes
4 and 5) was divided in two and immunoprecipitated with either an mAb
that recognizes a COOH-terminal  -catenin epitope ( C-mAb (M5.2), lane
4) or an NH2-terminal  -catenin epitope ( N-mAb (1.1), lane 5). As a control,
these antibodies were used to immunoprecipitate  -catenin from the total
starting material (not previously depleted with cad-GST; lanes 6 and 7).JCB • VOLUME 167 • NUMBER 2 • 2004 342
cytosolic fractions by gel filtration chromatography (Fig. 4).
We began our analysis with Xenopus embryos, because it was
easier to obtain a large amount of cytosolic  -catenin from cell
lysates (Fig. 4 A). One half of each column fraction was pre-
cipitated with TCA to show the total profile of  -catenin (Fig.
4 A, top blot); the other half was subjected to cadherin-GST af-
finity precipitation.  -Catenin eluted across a number of frac-
tions extending from 66 kD (BSA standard, peak fraction 37)
to 232 kD (catalase standard, peak fraction 30). The major
peak corresponded to  100 kD (fraction 35), suggesting that
most of the cytosolic  -catenin is monomeric. Importantly,
only fractions from the higher molecular mass “shoulder” of
the broad  -catenin profile were able to interact with the cad-
herin cytoplasmic domain (Fig. 4 A, middle blot), whereas
TCF could also bind the lower molecular sized fractions corre-
sponding to the major peak (Fig. 4 B below and not depicted).
The high molecular weight cadherin-binding fractions cofrac-
tionated with  -catenin (Fig. 4 A, bottom blot), suggesting that
they contain  -catenin– -catenin dimers. A similar binding
profile was observed with a cytosolic lysate from Wnt-express-
ing Rat1 cells (Fig. 4 B). However unlike in Xenopus, the cad-
herin-binding fractions did not perfectly cofractionate with the
 -catenin-containing fractions (Fig. 4 B). This small difference
in fractionation profiles may be due to the presence of  -cate-
nin homodimers, which may fractionate differently than
 -catenin– -catenin dimers during gel filtration (Koslov et al.,
1997). Nevertheless, the cadherin preferentially binds a form of
 -catenin that cofractionates with  -catenin, rather than the
smaller molecular size fractions, which can bind TCF. Further-
more, the preferential binding of  -catenin to TCF compared
with the cadherin observed in Fig. 1 appears to be due to an
ability of TCF, but not the cadherin, to bind the monomeric
form of  -catenin.
The higher molecular size fractions of  -catenin could be
due to its association with  -catenin or other possible proteins.
To see what proteins associate with  -catenin and bind to cad-
GST and TCF-GST fusion proteins, we performed the binding
assay using cytosol prepared from [
35S]methionine and cys-
teine-labeling cells. Metabolic labeling of Wnt   expressing
cells reveals  -catenin as the major binding partner of cytosolic
 -catenin (Fig. 5 A, lanes 6 and 7). No other major bands were
detected between the 10–200 kD molecular mass region by
Figure 3. Differential binding activity of
recombinant  -catenin as revealed by deletion
analysis. (A) Schematic representation of
 -catenin constructs. WT-myc-Xenopus   -cate-
nin and GSK3  mutant (S/T A residues 33,
37, 41, and 45)  -catenin were described
previously by Guger and Gumbiner (2000).
WT-human   -catenin-flag,   C695-flag and
 N89-flag constructs were described in Kol-
ligs et al. (1999). The myc-tagged, Xenopus
 -catenin construct encoding only the arm re-
peat region of  -catenin was described pre-
viously (Funayama et al., 1995). (B) Recom-
binant   -catenin binding to cad-GST versus
TCF-GST proteins. HEK293T cells were trans-
fected with decreasing amounts of  -catenin
plasmid and incubated in the presence ( ) of
Wnt3a conditioned media (CM). Cytosolic
fractions were affinity precipitated and immu-
noblotted with anti-myc, -flag, or  -catenin an-
tibodies. Input amounts of wild-type  -catenin,
  C695, and arm 12 constructs were the
same in accordance with similar expression
levels (not depicted).
Figure 4. Larger molecular size,  -catenin–containing fractions of  -catenin
show preferential binding to cad-GST. (A) A cytosolic fraction from stage
12 Xenopus embryos was applied to a Sephacryl 300 gel filtration column,
and fractions 28–39 were divided in two: one half of each sample was
TCA-precipitated (top blot), whereas the other half was precipitated with
cad-GST (middle blot). The top blot was reprobed with an antibody to
 -catenin and is shown below. (B) Same as A except that starting material
is an S100 fraction from Rat1/Wnt cells. Arrows refer to elution volumes
of standard proteins with known molecular weight: (a) catalase (Mr  
232,000); (b) BSA (Mr   66,000), purified mouse IgG (150 kD) eluted
in fractions 31–33.DISTINCT ADHESION AND SIGNALING FORMS OF  -CATENIN • GOTTARDI AND GUMBINER 343
[
35S]methionine/cysteine labeling or Coomassie staining (un-
published data). The cadherin-GST appears to affinity precipi-
tate  -catenin and  -catenin bands at a ratio  1:1, whereas the
TCF-GST precipitates much more  -catenin than  -catenin
(band ratios of  3:1; Fig. 5 A, lanes 8 and 9). Given that
 -catenin and  -catenin contain nearly identical numbers of
cysteine and methionine residues (40 and 41, respectively), and
that the labeling time is long (13 h) compared with the half
lives of both proteins (7 and 5 h, respectively; unpublished
data), it appears that the cadherin binds a stoichiometric com-
plex of  -catenin– -catenin. We conclude, therefore, that the
cadherin preferentially binds  -catenin that is associated with
 -catenin, whereas TCF can bind monomeric  -catenin in ad-
dition to  -catenin– -catenin dimers.
We determined in Fig. 2 D that a COOH-terminal epitope
of  -catenin was inaccessible in the fraction of  -catenin that
could not interact with the cadherin. Because our experiments
in Figs. 4 and 5 A showed that  -catenin– -catenin dimers
preferentially interact with the cadherin, we asked whether this
COOH-terminal epitope of  -catenin was accessible in the
 -catenin– -catenin dimer fraction, and masked in the form of
 -catenin that preferentially binds to TCF. To do so, we immu-
noprecipitated  -catenin from metabolically labeled, Wnt1-
expressing cells using the NH2- and COOH-terminal monospe-
cific antibodies previously shown to recognize distinct forms
of   -catenin (Fig. 2 D). The antibody that recognizes the
COOH terminus of  -catenin appears to preferentially immu-
noprecipitate  -catenin and  -catenin bands at a ratio of  1:1,
whereas the antibody that recognizes the NH2 terminus of
 -catenin immunoprecipitates significantly more  -catenin
than  -catenin (Fig. 5 B, lanes 1–4). Thus, the NH2-terminal
antibody can immunoprecipitate  -catenin monomers as well as
 -catenin– -catenin dimers. Because the COOH-terminal anti-
body preferentially immunoprecipitates  -catenin– -catenin
dimers, the COOH terminus in most of the monomeric fraction
of  -catenin is masked. To determine whether this inaccessibil-
ity of the COOH-terminal epitope was due to a more general
masking of the COOH terminus, we examined the binding of
 -catenin to the PDZ-containing protein, Lin7. The extreme
COOH terminus of  -catenin contains a PDZ interaction motif,
and has been shown previously to bind Lin 7 (Perego et al., 2000).
Similar to the COOH-terminal antibody findings, Lin7 affinity
precipitates  -catenin and  -catenin bands at a ratio of  1:1,
suggesting that it preferentially interacts with  -catenin– -cate-
nin dimers. Together, these results show that the COOH-termi-
nal region of  -catenin is accessible in the  -catenin– -catenin
dimer fraction, and is masked in the monomeric fraction, which
is enriched in the TCF-selective form of  -catenin.
Effect of APC mutations, inhibition of 
GSK-3  activity, NH2-terminal 
phosphorylation of  -catenin, and 
cadherin phosphorylation on  -catenin 
binding specificity
To explore the signaling pathways that might control these
forms of  -catenin, we sought to examine the role of the APC
tumor suppressor gene product and glycogen synthase kinase
(GSK)-3 , two key components in the Wnt pathway, as well as
the role of known phosphorylations of  -catenin in response to
Wnts. We examined several colon carcinoma cell lines that
contain either wild-type or mutant forms of APC (Fig. 6 A). All
of these cell lines manifest constitutive  -catenin signaling due
to inactivating mutations in APC (HT29, DLD1), or activating
mutations within the GSK-3  regulatory region of  -catenin
(HCT116). No differences in  -catenin binding to cadherin-
and TCF-GST fusion proteins were observed, suggesting that
 -catenin binding selectivity is not simply due to inhibition of
APC-mediated destruction of  -catenin. Interestingly, the role
of GSK-3  is more complex. Short-term inhibition of GSK3 
by lithium chloride (LiCl; under 4 h at 10 mM) mimics the Wnt
effect on  -catenin, i.e.,  -catenin preferentially binds TCF-
GST greater than cad-GST (Fig. 6 B, lanes 1 and 2). Therefore,
Figure 5. The  -catenin–free, monomeric form of  -catenin
exhibits preferential binding to TCF compared with cad-
herin in Wnt cells. (A) Rat1 cells were labeled to steady-
state with [
35S]methionine/cysteine, and a cytosolic frac-
tion was prepared from each condition ( Wnt,  Wnt,
10 mM LiCl, 12 h) and immunoprecipitated with the
designated antibodies or affinity precipitated with GST
proteins. Note that immunoprecipitation of endogenous
E-cadherin (from the 100,000 g membrane pellet, lanes
5, 10, and 16) and TCF (lane 11) are also shown. Non-
specific bands were not seen with a GST control (not
depicted). Overnight incubation with LiCl (10 mM) allows
the  -catenin–free pool of  -catenin to bind cad-GST, TCF-
GST, and the endogenous E-cadherin (lanes 14–16),
equivalently. (B). COOH-terminal epitopes of  -catenin
are masked in the  -catenin–free fraction of  -catenin.
Equivalent amounts of an S100 fraction from [
35S]methio-
nine/cysteine steady-state–labeled Rat1 Wnt cells were
immunoprecipitated with the following antibodies: anti–
 -catenin NH2-terminal mAb (1.1.1; lane 1), anti– -cate-
nin COOH-terminal mAb (M5.2; lane 2), anti– -catenin
mAb (lane 4), and a nonimmune control (lane 3). (Lanes
5–7) PDZ protein, mLin7, preferentially binds to  -catenin–
 -catenin dimer: metabolically labeled Rat1 Wnt lysates
were affinity precipitated with (lane 5) anti– -catenin pAb,
(lane 6) control GST, and (lane 7) mLin7-GST.JCB • VOLUME 167 • NUMBER 2 • 2004 344
inhibition of GSK3  activity alone is sufficient to mimic the
effect of Wnt on  -catenin binding activities. Curiously, how-
ever, long-term inhibition of GSK3  by LiCl (over 6 h at 10
mM) generates a pool of  -catenin that binds TCF and cad-
herin-GST proteins equally well (Fig. 6 B, lanes 3–6). Thus,
more potent effects of LiCl do not mimic Wnt signaling, but in-
stead result in the accumulation of high levels of  -catenin
with no binding specificity, similar to tumor cells with APC
mutations. One interpretation of these two types of effects is
that GSK might have multiple targets besides the NH2 terminus
of  -catenin (e.g., APC, Rubinfeld et al., 1996; or Axin, Jho et
al., 1999). Alternatively, long-term incubation with LiCl could
have pleiotropic effects on cell signaling pathways, or the cel-
lular machinery that regulates  -catenin binding to TCF versus
cadherin may be easily saturable, so that differential binding is
not observed when  -catenin levels rise to unphysiological lev-
els. This explanation is consistent with findings that total cyto-
solic levels of  -catenin appear to increase substantially with
the duration of LiCl treatment (Fig. 6 B, compare lanes 2, 4,
and 6), and because expression levels via transfection give sim-
ilar results (Fig. 3).
Several well-characterized NH2-terminal GSK phosphor-
ylation sites are known to target  -catenin for degradation by
an SCF-E3-ligase complex (Winston et al., 1999), and recent
work has shown that Wnt signaling is specifically mediated
through forms of  -catenin that remain unphosphorylated at
these NH2-terminal sites S-33, -37, and T-41 (Staal et al.,
2002). We therefore asked whether the state of phosphorylation
at these sites is responsible for generating the form of  -catenin
selective for TCF-binding. A pAb that recognizes NH2-termi-
nal, unphosphorylated  -catenin was shown to stain cell nuclei,
whereas cell–cell contact staining was conspicuously absent
(Staal et al., 2002), raising the possibility that unphosphory-
lated forms of  -catenin might preferentially bind to TCF in
the nucleus, and be unable to bind cadherins at the plasma
membrane. Contrary to this suggestion, however, we find that
 -catenin that is not phosphorylated at residues 33 and 37 can
interact with the cad-GST in vitro (Fig. 7 A), associate with en-
dogenous cadherin proteins in cell lysates (not depicted), and
localize to sites of cell–cell contact (not the nucleus, as origi-
nally observed in Staal et al., 2002; Fig. 7 B). Moreover, cells
transfected with a form of  -catenin that cannot be phosphory-
lated by GSK3  and casein kinase (CK1; S/T A point mu-
tants at residues 33, 37, 41 and 45) exhibit binding selectivity
similar to cells transfected with wild-type  -catenin (Fig. 3).
Thus, the preferential binding of  -catenin to TCF over cad-
herin is not simply due to NH2-terminal phosphorylation status.
We also asked whether modification of the cadherin
could affect  -catenin binding selectivity. A previous study
showed that the serine-rich,  -catenin binding region of the
cadherin is phosphorylated in vivo (Stappert and Kemler,
1994), and this phosphorylation can enhance  -catenin bind-
ing to the cadherin (Lickert et al., 2000; Huber and Weis,
2001). We therefore wished to explore whether  -catenin
binding selectivity for TCF in Wnt stimulated cells would be
altered by cadherin phosphorylation in our binding assay.
Phosphorylation of the cadherin greatly enhances binding to
 -catenin compared with unphosphorylated cadherin (Fig. 8 A
and Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200402153/DC1). Indeed, phospho-cadherin is able to
binding the same fraction of  -catenin that binds TCF (Fig. 8,
B and C), suggesting that cadherin phosphorylation allows the
monomeric, closed form of  -catenin to bind the cadherin.
Thus, although Wnt signaling generates a form of  -catenin
that exhibits preferential binding to TCF over the cadherin,
this mechanism can be overridden by extensive phosphoryla-
tion of the cadherin.
Discussion
We show that Wnt signaling generates a monomeric form of
 -catenin that binds TCF selectively compared with the cad-
herin. In contrast, the cadherin preferentially binds a  -catenin–
 -catenin dimer. This selective targeting of distinct molecular
forms of  -catenin provides a mechanism by which cells could
potentially separate the adhesion and signaling functions of
 -catenin. We propose that segregation of these functions of
 -catenin may be necessary for two reasons. First, selective tar-
geting of  -catenin to transcriptional complexes would prevent
the cadherin from competing with Wnt signaling activity,
which may be important during low or transient Wnt activation
where signaling may need to be especially efficient. Second,
such a mechanism would ensure that cell–cell adhesion is main-
tained during Wnt inductions throughout development. Loading
the cadherin with  -catenin monomers generated by strong Wnt
signals might have undesired consequences for cell adhesion,
because cadherins bound to  -catenin without  -catenin would
be unable to contribute to adhesion. Thus, generation and tar-
geting of distinct molecular forms of  -catenin could ensure
that adhesion and signaling are not always coupled, and when
necessary, can be regulated independently of one another.
Figure 6.  -Catenin binding selectivity as a function of APC mutant status
or GSK inhibition by LiCl. (A) A cytosolic fraction was prepared from colon
carcinoma cell lines containing wild-type (HCT116) or mutant (HT29 and
DLD1) forms of APC. (B) Selective binding activity of  -catenin in response
to short-term, but not long-term treatment with LiCl. HEK293T cells were
treated with 10 mM LiCl for 3, 6, and 15 h, after which cytosolic fractions
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We provide evidence that the Wnt-stimulated, TCF-bind-
ing selectivity of  -catenin is mediated by the COOH-terminal
region of  -catenin. First, COOH-terminal epitopes of  -cate-
nin are masked in the fraction of  -catenin that is unable bind
the cadherin. Second, a COOH-terminal peptide of  -catenin
can compete  -catenin binding to cadherin, but not to TCF.
Third, deletion of the COOH terminus of  -catenin results in a
loss of binding selectivity. Together with previously published
data showing that the COOH-terminal region of  -catenin can
bind directly to the armadillo repeat region of  -catenin (Cox
et al., 1999; Piedra et al., 2001) and restrict cadherin binding in
vitro (Castano et al., 2002), we propose that in vivo, the COOH
terminus of  -catenin adopts a folded-over conformation
which controls  -catenin binding selectivity by restricting cad-
herin but not TCF binding. Thus, Wnts may activate  -catenin
signaling not only by increasing its cytosolic levels, but by reg-
ulating the conformation of its COOH terminus.
The existence of a form of  -catenin that distinguishes
between cadherins and TCF was not anticipated, given the
overall structural similarity between the  -catenin–cadherin
and  -catenin–TCF binding interfaces revealed by X-ray crys-
tallography (Graham et al., 2000; Huber and Weis, 2001). Upon
closer examination, however, the  -catenin–TCF binding inter-
face is less extensive than the  -catenin–cadherin binding in-
terface, spanning arm repeats 3–10 compared with all 12 ar-
madillo repeats for the cadherin. Thus, it is possible that the
COOH-terminal region of  -catenin may fold-back over the last
two armadillo repeats of  -catenin, which could have conse-
quences for cadherin but not TCF binding. Indeed, alteration of a
single residue in the 12th arm repeat of  -catenin decreases
 -catenin binding to the cadherin by a factor of four (Roura et al.,
1999), further arguing that small perturbations in the  -catenin–
cadherin interface can have significant consequences for binding.
It has also been shown that phosphorylation of E-cad-
herin increases cadherin– -catenin complex formation (Lickert
et al., 2000). In crystal structures, this phosphorylation results
in interactions with  -catenin that appear to mimic TCF bind-
ing (Huber and Weis, 2001). Indeed, we find that cadherin
phosphorylation allows the cadherin to bind the monomeric,
closed form of  -catenin that otherwise would be TCF selec-
tive. The fact that cadherin phosphorylation can reverse Wnt-
mediated  -catenin binding selectivity suggests a mechanism
by which cadherins compete for the Wnt-activated form of
 -catenin. It will be important, therefore, to determine when
and where cadherin modification occurs to better understand
the relationship between adhesion and signaling.
Figure 7.   -Catenin not phosphorylated at NH2-terminal
GSK-3  sites binds to cadherin. (A) Cytosolic fraction
from HEK293 cells   Wnt3a was affinity precipitated
with cad-GST and TCF-GST, and blotted with pAbs to
 -catenin (top blot) or NH2-terminal unphosphorylated–
 -catenin (amino acids 27–37, bottom blot). (B) NH2-
terminal unphospho– -catenin localizes to sites of cell–
cell contact in Wnt-expressing cells. Rat1 fibroblasts  
Wnt were fixed and processed for immunofluorescence
using standard protocols. Images were captured with the
Axioplan 2 microscope and AxioVision2.0 software
(Carl Zeiss MicroImaging, Inc.). Note that membrane
staining of the unphospho- -catenin (Cy3) is more readily
detected under methanol, rather than PFA fixation condi-
tions, perhaps accounting for the apparent differences
observed between our study and Staal et al. (2002).JCB • VOLUME 167 • NUMBER 2 • 2004 346
Our observation that the cadherin binds preferentially to
 -catenin– -catenin dimers compared with  -catenin mono-
mers raises the possibility that  -catenin plays a positive role in
 -catenin binding to cadherin. Indeed, one study showed that
preassociation of recombinant  -catenin with  -catenin in-
creases  -catenin binding to cadherin, suggesting that  -cate-
nin induces an open conformation of  -catenin (Castano et al.,
2002). Other evidence, however, argues that  -catenin is not
required for  -catenin binding to cadherin. For example, re-
combinant cadherin– -catenin complexes are readily formed in
vitro (Huber et al., 2001), and cells lacking  -catenin still form
cadherin– -catenin complexes (Bullions et al., 1997; Vasiou-
khin et al., 2001). We suggest that the form of  -catenin that
binds preferentially to cadherin, also binds  -catenin.
Based on our findings from this and previous reports, we
propose that cells contain a number of distinct molecular forms
of  -catenin (Fig. 9). Thus, although an organism like C. ele-
gans controls the adhesive and signaling functions of  -catenin
through expression of a multi-gene family, vertebrates regulate
 -catenin functions by generating distinct molecular forms at
the protein level. First, there is the well-known form of  -cate-
nin that is phosphorylated at the NH2 terminus and is targeted
for degradation (Fig. 9, phosphorylated; for review see Polakis,
1999). We reported previously a large pool of  -catenin in the
SW480 tumor cell line that cannot bind to either TCF or cad-
herin, and provided evidence that this was an “inactive” form
for both adhesion and signaling (Fig. 9; Gottardi et al., 2001).
This form may be due, at least in part, to ICAT, a small 9-kD
polypeptide that inhibits  -catenin binding to both TCF and
cadherin (Gottardi and Gumbiner, 2004; Tago et al., 2000).
Here, we provide evidence for a TCF-selective form of  -cate-
nin that is targeted to transcription complexes (closed conforma-
tion), and a form that can target to adhesive complexes ( -cate-
nin– -catenin dimer). Although the latter form can interact with
both the cadherin and TCF, there is evidence that  -catenin in-
hibits the transcriptional activity of  -catenin in the nucleus
(Giannini et al., 2000), suggesting that this form is specific for
adhesion functions. Finally, we postulate that cells can contain a
form of  -catenin that is competent for both signaling and cad-
herin binding (open conformation) which is observed, for exam-
ple, under long-term LiCl treatment (Fig. 5 A, lanes 14 and 15),
and would explain the many cases in which cadherin expression
inhibits the transcriptional activity of  -catenin (Heasman et al.,
1994; Fagotto et al., 1996; Sanson et al., 1996; Orsulic et al.,
1999; Shtutman et al., 1999; Gottardi et al., 2001).
Other than the targeting of  -catenin for degradation, the
modifications and machinery that regulate these various forms
of  -catenin are presently unknown. It is not clear, for exam-
ple, whether the formation of the inactive ICAT complex is
simply controlled by levels of ICAT expression, or is regulated
in another way (Gottardi and Gumbiner, 2004). Also, it is not
understood what controls the formation of the  -catenin–
 -catenin dimer, although it is clear that  -catenin monomers
and  -catenin can coexist in the cytosol without forming com-
plexes, even though they readily bind with high affinity in vitro
(Koslov et al., 1997). Nor is the time and place of cadherin
phosphorylation known. We show that the TCF-selective,
Figure 8. Cadherin phosphorylation reverses  -catenin binding selectivity
during Wnt signaling. (A) Phosphorylation of cad-GST increases  -catenin
binding to cadherin compared with TCF. A cytosolic fraction from L cells
transfected with Wnt3a were incubated with equimolar amounts of cad-
GST, TCF-GST, and CK2-P-cad-GST-glutathione–coupled beads for 1 h at
4 C (see Fig. S1 for characterization of GST fusion proteins). The result-
ing anti– -catenin and anti-GST immunoblots are shown. (B) Fraction of
 -catenin that binds cadherin is a subset of fraction of  -catenin that
binds TCF. Cytosolic fraction of Wnt cells was sequentially affinity precip-
itated with cad-GST (lanes 1–3) or TCF-GST (lanes 6–8) proteins. After
cad-GST depletion (lanes 1–3), half of the cad-GST non-binding fraction
(NB/2) was precipitated with TCF-GST (lane 4); the other half was pre-
cipitated with TCA to show amount remaining (lane 5, far right). After
TCF-GST depletion (lanes 6–8), half of the TCF-GST non-binding fraction
(NB/2, lane 9) was precipitated with cad-GST, whereas the other half
was precipitated with TCA to show amount remaining (lane 10, far
right). Lanes 5 and 10 reveal a fraction of  -catenin that binds neither
TCF nor cadherin. This fraction is likely due to  -catenin already com-
plexed with partners such as ICAT (Gottardi and Gumbiner, 2004). (C)
Phosphorylated cadherin-GST and TCF-GST bind the same pool of  -catenin
in Wnt-activated cells. Cytosolic fraction was precipitated with cad-GST
(top blot), TCF-GST (bottom left) or P-cadherin-GST (bottom right) fusion
proteins. After cad-GST depletion (lanes 2–4 and 7–9), there is a fraction
of  -catenin that binds TCF-GST (lane 5) and P-cadherin-GST (lane 10).
Note that after TCF-GST depletion (lanes 13–15), there is no  -catenin
remaining to bind P-cadherin-GST (lane 16). After P-cadherin-GST depletion
(lanes 18–20), there is no  -catenin remaining to bind TCF-GST (lane
21). Reciprocal depletions suggest that P-cadherin-GST and TCF-GST
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closed form of  -catenin is regulated by the Wnt pathway, and
that the binding selectivity observed after short-term LiCl treat-
ment suggests that GSK3  may be involved. However, the
mechanism must be distinct from the pathway that regulates
 -catenin levels in the cytosol, because the absence of GSK3 -
dependent NH2-terminal phosphorylation does not account for
its binding properties, and long-term LiCl treatments and APC
mutations lead to  -catenin accumulation without generating
the TCF-selective form. It is tempting to speculate that the
APC-axin-GSK3 –containing complex regulates the genera-
tion of these various forms of  -catenin by post-translational
modifications, in addition to the targeting of  -catenin for deg-
radation. Indeed APC mutations have been found to affect ad-
hesive functions of  -catenin as well as Wnt signaling in Dro-
sophila (Hamada and Bienz, 2002).
If we propose that Wnt signaling generates a TCF-selec-
tive form of  -catenin that is resistant to cadherin binding,
how do we explain the fact that cadherin expression has been
found to antagonize Wnt signaling in numerous model systems
(Heasman et al., 1994; Fagotto et al., 1996; Gottardi et al.,
2001)? One possibility is that cadherin overexpression of cad-
herin drives the formation of complexes that do not occur under
normal physiological conditions. Although the various molecu-
lar forms of  -catenin seem fairly stable in our experiments, it
is possible that they are more interconvertible in the cell, or that
one form is an intermediate for the other, and can be depleted
during its generation. A more interesting possibility is that the
relationship between cadherins and Wnt signaling may depend
on the specific situation faced by each cell responding to a Wnt
signal. For example, our finding that cadherin phosphorylation
increases  -catenin binding to cadherin, reversing the differen-
tial binding activity observed during Wnt signaling, suggests
that variations in cadherin phosphorylation may alter the extent
to which adhesion and signaling are coupled. We also hypothe-
size that the cell can potentially generate either the open form
of  -catenin, which binds to both cadherin and TCF, or the
closed, TCF-selective form, and the relative proportion of these
two forms may differ between different cells responding to
Wnt signaling, or different strengths of Wnt signaling.
Indeed, consideration of the various findings suggests a
model in which the extent of coupling between the adhesive and
nuclear signaling functions of  -catenin is regulated differen-
tially in different cell types, depending on the biological needs
of the cells and tissues responding to a Wnt signal. Elucidating
the cellular and biochemical mechanisms regulating the genera-
tion of the different forms of  -catenin and determining when
and where they occur should provide insight into the relation-
ship between the adhesive and signaling functions of  -catenin.
Materials and methods
Cell culture
C57MG and Rat1 parental and Wnt1-expressing cell lines were provided
by J. Kitajewski (Columbia University, New York, NY). Wnt3a-expressing
L cells were provided by L. Schweizer and H. Varmus (Sloan-Kettering In-
stitute, New York, NY). HEK293T, SW480, HCT116, DLD1, and HT29
cell lines were purchased from American Type Culture Collection.
Antibody and plasmid reagents
Rabbit pAbs to  -catenin, and the NH2-terminal region of  -catenin have
been described elsewhere (McCrea et al., 1993); 1:5,000 WB; 1:500
IP). The NH2-terminal and COOH-terminal monoclonal anti– -catenin anti-
bodies (1.1.1 and M5.2, respectively) were provided by N. Gruel, V.
Choumet, and J. Luc Teillard (Pasteur Institute, Paris, France). Other anti-
bodies used in this study: anti–NH2-terminal dephospho– -catenin pAb
(8E4; A.G. Scientific), anti– -catenin COOH-terminal mAb (C19220;
Transduction Laboratories), anti– -catenin mAb (BD Transduction Labora-
tories), anti–human E-cadherin (HECD-1 mAb; Zymed Laboratories; 1:500
IP), anti–TCF-4 (1:500 IP, 6H5-3; Upstate Biotechnology), anti-FLAG
epitope (1:5,000 WB, M2 mAb, Sigma-Aldrich) and anti-Myc (1:5,000
WB, 9E10 epitope). The mouse Lin7 GST fusion construct was provided
by S. Straight and B. Margolis (University of Michigan, Ann Arbor, MI).
Xenopus C-cadherin cytoplasmic domain (cad-GST) and Xenopus TCF-3
 -catenin binding region (TCF-GST) fusion proteins have been described
previously (Gottardi et al., 2001).
Affinity precipitation experiments
Cells were grown to in 14-cm tissue culture dishes and a detergent-free,
cytosolic fraction was generated by centrifugation at 100,000 g accord-
Figure 9. Multiple forms of  -catenin exist in cells.
NH2-terminal phospho- -catenin is well characterized and
generated by the APC-Axin-GSK3 -CK1 complex (dashed
line). Closed form of  -catenin is generated by Wnt sig-
naling, perhaps through some of the same machinery
(gray arrow).  -Catenin– -catenin dimer is active for
adhesion but not signaling. Open form binds both cadherin
and TCF, and could explain how cadherin antagonizes
 -catenin signaling in overexpression systems. The inactive
form cannot participate in adhesion or signaling.JCB • VOLUME 167 • NUMBER 2 • 2004 348
ing to Gottardi et al. (2001). Metabolic labeling of proteins with [
35S]me-
thionine/cysteine was done according to Gottardi and Gumbiner (2004).
Affinity precipitations were performed with recombinant GST-cad, GST-TCF
and GST-mLin7 fusion proteins. For cadherin/TCF-GST binding experi-
ments, 100–500  g of a cytosolic fraction was subjected to affinity pre-
cipitation with  40 pmol of cad-GST or TCF-GST prebound as a 50% sus-
pension of glutathione-coupled agarose beads (Sigma-Aldrich) for 60  at
4 C. Each precipitation was washed in a detergent buffer (50 mM Tris,
pH 7.5, 2 mM EDTA, 150 mM NaCl and 0.1% NP-40), and bound pro-
tein complexes were analyzed by standard Western analysis. For in vitro
competition of the  -cat COOH-terminal peptide (amino acids 696–781;
provided by A. Garcia de Herreros, Universitat Pompeu Fabra, Barce-
lona; Castano et al., 2002), the  -catenin COOH terminus was cleaved
from GST with PreScission protease (Amersham Biosciences).  -Catenin
( 17 pmol, produced by the baculovirus system), cadherin-GST (51 pmol),
or TCF-GST (51 pmol) were incubated in 150 ml of buffer (10 mM Tris,
pH 8.0, 140 mM NaCl, 1 mM EDTA, 0.1% NP-40, 10  g/ml leupeptin
and aprotinin) for 60’ at 4 C with shaking in the presence or absence of
increasing amounts of the  -catenin COOH-terminal peptide (0, 0.1, 1.0,
5.0, and 15.0  g [1.6 nmol peptide]).  -Catenin that was affinity precipi-
tated by cadherin-GST and TCF-GST immobilized to glutathione-coupled
agarose was washed and subjected to SDS-PAGE and Western analysis.
Gel filtration chromatography
The cytosolic fraction was separated on a Hi Prep 16/60 Sephacryl
S-300 sizing column (Amersham Biosciences; High Resolution Code 17–
1167-01, 10–1500 kD inclusion range) equilibrated with buffer contain-
ing 30 mM Hepes, pH 7.5, and 150 mM KCl and developed at 0.4 ml/
min. 75 2.0-ml fractions were collected.
Online supplemental material
Fig. S1 depicts in vitro phosphorylation of cadherin-GST. (A) Purification
of cad-GST and TCF-GST proteins and detection by Coomassie. (B and C)
In vitro phosphorylation of cad-GST by CK-2. Cad-GST (3  g) was incu-
bated with or without 50 U of recombinant human CK-2 (New England
Biolabs, Inc.) and 200 or 600  M ATP using conditions suggested by the
manufacturer. Cad-GST input was evaluated with an antibody to GST; ev-
idence for phosphorylation was detected by immunoblotting with an anti–
P-serine antibody (Sigma-Aldrich). (C) Efficiency of cad-GST phosphoryla-
tion: the first and sixth lanes in B were resolved on a long gel to detect the
mobility shift of phospho-cad-GST. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200402153/DC1.
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